Nexalin Technology Closes $5 Million Public Offering to Support Neurostimulation Innovations
HOUSTON, May 6, 2025 (GLOBE NEWSWIRE) – Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), a pioneer in Deep Intracranial Frequency Stimulation (DIFS™) technology, has successfully completed a public offering of 3,850,000 shares of its common stock at $1.30 per share, raising approximately $5 million in gross proceeds before expenses. Maxim Group LLC served as the sole book-running manager for the offering.
The public offering followed an effective shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC) on April 23, 2025, and approved on April 29, 2025. Investors can access the final prospectus supplement outlining the offering’s terms on the SEC’s website or by contacting Maxim Group LLC directly.
Nexalin Technology is committed to addressing the critical global mental health crisis. The company develops non-invasive neurostimulation devices aimed at alleviating mental health issues by targeting deep structures within the mid-brain. The revolutionary Nexalin Gen-2 device has already received approval for use in China, Brazil, and Oman, and is expected to enhance patient outcomes with no adverse side effects, thanks to its innovative waveform technology.
This announcement aligns with Nexalin’s strategic vision to leverage bioelectronic medical technologies to create advanced solutions for mental health treatment. "Our investment initiatives are crucial to furthering our research and development efforts, ensuring we continue to meet the needs of individuals struggling with mental health challenges," said a company spokesperson.
For potential investors, it is important to note that this press release does not constitute an offer to sell or solicitation for the purchase of securities.
For more information about Nexalin Technology and its pioneering solutions, please visit nexalin.com.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
